» Authors » Jose Luis Lobo

Jose Luis Lobo

Explore the profile of Jose Luis Lobo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 45
Citations 998
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lyhne M, Bikdeli B, Jimenez D, Kabrhel C, Dudzinski D, Moises J, et al.
Eur Heart J Acute Cardiovasc Care . 2024 Oct; 13(12):817-825. PMID: 39442929
Aims: Acute pulmonary embolism (PE) increases pulmonary pressure and impair right ventricular (RV) function. Echocardiographic investigation can quantify this mismatch as the tricuspid annular plane systolic excursion (TAPSE) to pulmonary...
2.
Lyhne M, Bikdeli B, Dudzinski D, Muriel-Garcia A, Kabrhel C, Sancho-Bueso T, et al.
TH Open . 2024 Jan; 8(1):e1-e8. PMID: 38197015
 In acute pulmonary embolism (PE), echocardiographic identification of right ventricular (RV) dysfunction will inform prognostication and clinical decision-making. Registro Informatizado Enfermedad TromboEmbolica (RIETE) is the world's largest registry of patients...
3.
Becattini C, Giustozzi M, Portillo J, Fernandez-Capitan C, Lobo J, Peris M, et al.
Res Pract Thromb Haemost . 2023 Oct; 7(6):102172. PMID: 37810416
Background: Patients with brain cancer have been excluded or were underrepresented in studies on the treatment of venous thromboembolism (VTE), mainly due to the fear of intracranial hemorrhage (ICH). Objectives:...
4.
Barrios D, Duran D, Rodriguez C, Moises J, Retegui A, Lobo J, et al.
Chest . 2023 Sep; 165(3):673-681. PMID: 37717936
Background: The effect of supplemental oxygen therapy in patients with intermediate-risk pulmonary embolism (PE) who do not have hypoxemia at baseline is uncertain. Research Question: Does supplemental oxygen improve echocardiographic...
5.
Otero R, Lobo J, Lopez R, Fernandez C, Jimenez D, Muriel A, et al.
Thromb Res . 2023 Jun; 228:1-9. PMID: 37263121
Introduction: Chronic thromboembolic pulmonary hypertension (CTEPH) is a long-term sequel to pulmonary embolism (PE) whose incidence varies according to different published studies. We have carried out this study to determine...
6.
Garcia-Ortega A, Mora V, Lobo J
Arch Bronconeumol . 2022 Oct; 59(3):131-133. PMID: 36229302
No abstract available.
7.
Ruiz-Artacho P, Lecumberri R, Trujillo-Santos J, Font C, Lopez-Nunez J, Peris M, et al.
Cancers (Basel) . 2022 Sep; 14(17). PMID: 36077663
In patients with lung cancer and venous thromboembolism (VTE), the influence of cancer histology on outcome has not been consistently evaluated. We used the RIETE registry (Registro Informatizado Enfermedad TromboEmbólica)...
8.
Lobo J, Jimenez D
Arch Bronconeumol . 2022 Jun; 57(9):612. PMID: 35702921
No abstract available.
9.
Siniscalchi C, Muriel A, Surinach Caralt J, Bikdeli B, Jimenez D, Lobo J, et al.
J Thromb Haemost . 2022 May; 20(8):1839-1851. PMID: 35510755
Background: Statins possess antithrombotic and profibrinolytic properties. The association between statin use and short-term outcomes in patients with acute pulmonary embolism (PE) remains unknown. Methods: We used the data from...
10.
Jimenez D, Rodriguez C, Pintado B, Perez A, Jara-Palomares L, Lopez-Reyes R, et al.
Front Cardiovasc Med . 2022 May; 9:872115. PMID: 35497990
Background: A recent trial showed that management driven by prognostic assessment was effective in reducing the length of stay (LOS) for acute stable pulmonary embolism (PE). The efficacy and safety...